Diurnal secures second US patent for Chronocort – Pharmaceutical Business Review

Diurnal secures second US patent for Chronocort  Pharmaceutical Business Review

UK-based specialty pharma company Diurnal Group said that the US Patent and Trademark Office (USPTO) has granted a second US patent for Chronocort …